Lupin Signs Promotional Agreement with Exeltis on SOLOSEC® (secnidazole) expanding access for Adult Women Suffering with Bacterial Vaginosis and Adults with Trichomoniasis

/PRNewswire/ -- Lupin Pharmaceuticals Inc., (Lupin), and Exeltis USA Inc. announced a promotional agreement for Exeltis to promote SOLOSEC® along with Exeltis'...

Related Keywords

United States ,Exeltis Salustiano Perez ,Insud Pharma ,Vinita Gupta ,Shweta Munjal ,Lupin Pharmaceuticals Inc ,Exeltis United States Inc ,Prnewswire Lupin Pharmaceuticals Inc ,Corporate Communications ,Women Health ,Lupin Inc ,Pharmaceuticals Inc ,Exeltis United States ,Bacterial Vaginosis ,Healthcare Providers ,Chief Executive Officer ,Central Nervous System ,Lupin Pharmaceuticals ,Important Safety ,Florham Park ,Lupin Limited ,All Rights ,Harbor Statement ,Securities Litigation Reform Act ,Transmitted Diseasestreatment Guidelines ,Human Microbiome During Bacterial ,Clin Microbiol ,Global Head ,Nc ,